Wugen Announces Presentation of WU-NK-101 Preclinical Data at the European Society for Medical Oncology (ESMO) Congress 2022 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of allogeneic cell therapies to treat a broad range of hematological and solid tumor malignancies, today announced it will
MIAMI, Aug. 25, 2022 Longeveron Inc. , a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, today announced that. | August 25, 2022
Longeveron Inc. (NASDAQ:NASDAQ:LGVN) Q2 2022 Earnings Conference Call August 12, 2022 08:30 AM ET Company Participants Elsie Yau - Stern Investor Relations Chris Min - Interim Chief.